AMH Equity Ltd Makes New $703,000 Investment in Aspen Aerogels, Inc. (NYSE:ASPN)

AMH Equity Ltd bought a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 110,000 shares of the construction company's stock, valued at approximately $703,000. AMH Equity Ltd owned approximately 0.13% of Aspen Aerogels at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the stock. Vanguard Group Inc. lifted its position in Aspen Aerogels by 5.5% during the 4th quarter. Vanguard Group Inc. now owns 4,360,246 shares of the construction company's stock valued at $51,800,000 after acquiring an additional 226,251 shares during the period. Oaktop Capital Management II L.P. increased its stake in shares of Aspen Aerogels by 5.6% during the fourth quarter. Oaktop Capital Management II L.P. now owns 3,740,525 shares of the construction company's stock valued at $44,437,000 after purchasing an additional 200,000 shares in the last quarter. Needham Investment Management LLC lifted its holdings in shares of Aspen Aerogels by 5.2% during the fourth quarter. Needham Investment Management LLC now owns 2,389,700 shares of the construction company's stock valued at $28,390,000 after purchasing an additional 117,500 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Aspen Aerogels by 25.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,018,631 shares of the construction company's stock worth $23,983,000 after purchasing an additional 409,862 shares in the last quarter. Finally, Millennium Management LLC grew its stake in shares of Aspen Aerogels by 4,757.8% in the 4th quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company's stock worth $19,270,000 after buying an additional 1,588,632 shares during the last quarter. Institutional investors own 97.64% of the company's stock.

Insiders Place Their Bets

In other news, CEO Donald R. Young purchased 20,000 shares of the company's stock in a transaction dated Monday, May 12th. The shares were acquired at an average price of $5.35 per share, with a total value of $107,000.00. Following the transaction, the chief executive officer owned 550,856 shares of the company's stock, valued at $2,947,079.60. This represents a 3.77% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 4.30% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research analysts have recently weighed in on ASPN shares. Oppenheimer cut Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 8th. Barclays reissued an "equal weight" rating and set a $7.00 price objective (down from $13.00) on shares of Aspen Aerogels in a report on Thursday, May 29th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $18.44.

Aspen Aerogels Price Performance

Shares of ASPN stock traded up $0.57 during mid-day trading on Friday, hitting $7.23. The company had a trading volume of 2,611,289 shares, compared to its average volume of 2,036,944. The company has a market capitalization of $593.66 million, a P/E ratio of -2.07 and a beta of 2.65. The stock's 50 day moving average price is $6.22 and its 200-day moving average price is $7.57. Aspen Aerogels, Inc. has a 52-week low of $4.16 and a 52-week high of $33.15. The company has a debt-to-equity ratio of 0.40, a current ratio of 4.22 and a quick ratio of 3.53.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its earnings results on Thursday, May 8th. The construction company reported ($0.06) earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. The firm had revenue of $78.72 million for the quarter, compared to the consensus estimate of $82.75 million. Aspen Aerogels had a negative net margin of 65.47% and a positive return on equity of 6.69%. The business's quarterly revenue was down 16.7% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.02) EPS. Equities research analysts forecast that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.